51 results
424B5
GNLX
Genelux Corp
24 May 24
Prospectus supplement for primary offering
5:19pm
such reimbursement payments until the completion of its next round of financing, which Newsoara expects to occur in 2024.
Implications of Being … and reimbursement of Olvi-Vec, if approved; the potential benefits of strategic collaborations and our ability to enter into strategic arrangements; the timing
8-K
EX-1.1
GNLX
Genelux Corp
24 May 24
Entry into a Material Definitive Agreement
8:11am
be entitled to receive such reimbursement.
13. Research Analyst Independence. The Company acknowledges that the Underwriters’ research analysts
424B5
GNLX
Genelux Corp
23 May 24
Prospectus supplement for primary offering
4:59pm
such reimbursement payments until the completion of its next round of financing, which Newsoara expects to occur in 2024.
Implications of Being … to commercialize Olvi-Vec, if approved; the pricing and reimbursement of Olvi-Vec, if approved; the potential benefits of strategic collaborations
S-3
seyvmre b2pqrslq
2 Feb 24
Shelf registration
4:36pm
S-3
EX-4.14
y09dst6xn38sas83a2st
2 Feb 24
Shelf registration
4:36pm
S-8
ylqwef1ywtylr 6a4
15 Nov 23
Registration of securities for employees
12:00am
DEF 14A
bb5kp jnaohnwo4zmev
20 Jul 23
Definitive proxy
4:05pm
8-K
EX-10.1
r0yrrud9jll v5
2 Jun 23
Departure of Directors or Certain Officers
6:05am
10-Q
3zze6a
15 May 23
Quarterly report
12:00am
10-K
hrcaon u9
29 Mar 23
Annual report
5:12pm